We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$189B
AUM Growth
-$6.65B
Cap. Flow
-$21B
Cap. Flow %
-11.12%
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Healthcare 11.06%
3 Financials 8.17%
4 Consumer Discretionary 8.09%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANIP icon
3251
ANI Pharmaceuticals
ANIP
$1.8B
$1.04M ﹤0.01%
29,708
+2,798
+10% +$95.2K
ELF icon
3252
e.l.f. Beauty
ELF
$5.09B
$1.04M ﹤0.01%
37,698
+9,954
+36% +$285K
SVM
3253
Silvercorp Metals
SVM
$2.39B
$1.04M ﹤0.01%
189,505
-33,934
-15% -$197K
ENTA icon
3254
Enanta Pharmaceuticals
ENTA
$384M
$1.04M ﹤0.01%
23,588
-1,319
-5% -$64.6K
AGEN
3255
Agenus
AGEN
$324M
$1.04M ﹤0.01%
9,622
+714
+8% +$53.5K
MDLZ icon
3256
CALL
Mondelez International
MDLZ
$79.9B
$1.04M ﹤0.01%
16,600
+11,600
+232% +$715K
SCS
3257
DELISTED
Steelcase
SCS
$1.04M ﹤0.01%
70,149
+1,569
+2% +$22.6K
XLY icon
3258
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23B
$1.04M ﹤0.01%
11,600
-65,200
-85% -$5.68M
GFF icon
3259
Griffon
GFF
$4.72B
$1.03M ﹤0.01%
40,545
+539
+1% +$14.4K
VRTX icon
3260
CALL
Vertex Pharmaceuticals
VRTX
$123B
$1.03M ﹤0.01%
5,100
+800
+19% +$167K
TBI
3261
Trueblue
TBI
$301M
$1.03M ﹤0.01%
36,218
-38,231
-51% -$1.02M
VST.WS.A
3262
DELISTED
Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024)
VST.WS.A
$1.03M ﹤0.01%
+3,283,029
New +$1.03M
SWTX
3263
DELISTED
SpringWorks Therapeutics
SWTX
$1.02M ﹤0.01%
12,442
-1,047
-8% -$79.5K
SKYW icon
3264
Skywest
SKYW
$4.5B
$1.02M ﹤0.01%
23,773
+1,347
+6% +$66.4K
CUBI icon
3265
Customers Bancorp
CUBI
$2.79B
$1.02M ﹤0.01%
26,102
+4,408
+20% +$159K
TUP
3266
DELISTED
Tupperware Brands Corporation
TUP
$1.02M ﹤0.01%
43,333
-1,518
-3% -$38.5K
MCRB icon
3267
Seres Therapeutics
MCRB
$49.8M
$1.02M ﹤0.01%
2,141
-255
-11% -$108K
INVX
3268
Innovex International
INVX
$2.13B
$1.02M ﹤0.01%
30,026
-7,902
-21% -$266K
ESPO icon
3269
VanEck Video Gaming and eSports ETF
ESPO
$244M
$1.02M ﹤0.01%
+14,020
New +$985K
DMC
3270
Del Monte Corp
DMC
$1.4B
$1.02M ﹤0.01%
31,527
-2,576
-8% -$83.1K
IGIB icon
3271
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$1.02M ﹤0.01%
16,804
+13,269
+375% +$794K
FSP
3272
Franklin Street Properties
FSP
$48M
$1.02M ﹤0.01%
193,262
-28,806
-13% -$155K
NBHC icon
3273
National Bank Holdings
NBHC
$1.93B
$1.01M ﹤0.01%
27,851
-8,135
-23% -$322K
LMAT icon
3274
LeMaitre Vascular
LMAT
$1.81B
$1.01M ﹤0.01%
16,578
+3,964
+31% +$211K
IYH icon
3275
iShares US Healthcare ETF
IYH
$3.49B
$1.01M ﹤0.01%
18,520
-6,755
-27% -$358K

Similar funds

Credit Suisse's Q2 2021 Portfolio in Review

As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.

  • Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
  • Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
  • Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
  • Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
  • Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
  • Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
  • Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.